| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/15/2004 | US20040010001 Methods and compositions for modulating cell proliferation and cell death |
| 01/15/2004 | US20040009950 Secreted human proteins |
| 01/15/2004 | US20040009913 Detecting, identifying and screening for srf signal transduction pathway elements for diagnosis |
| 01/15/2004 | US20040009904 APL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies |
| 01/15/2004 | US20040009548 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
| 01/15/2004 | US20040009547 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
| 01/15/2004 | US20040009546 Compositions and methods for inhibiting microbial adhesion |
| 01/15/2004 | US20040009535 Comprises immunoglobulin which inhibits homodimer formation associated with a transforming growth factor polypeptide, sclerostin (SOST), for treating osteopenia, osteoporosis and bone fractures |
| 01/15/2004 | US20040009531 A quantitative analyzing the concentration of peptide with monoclonal antibody produced by the fused cell hybrid; medical diagnosis |
| 01/15/2004 | US20040009491 Diagnostic and therapeutic methods useful for diagnosing, treating, preventing and/or prognosing disorders related to plasma membrane associated polynucleotides, antigens, and antibodies |
| 01/15/2004 | US20040009195 Modified sialic acid vaccines |
| 01/15/2004 | US20040009192 Diagnosis of and vaccination against |
| 01/15/2004 | US20040009188 Present invention relates to a polypeptide antigen which derives from the gp41 protein, and also to the use thereof for immunization against HIV-related infection |
| 01/15/2004 | US20040009182 Administering donated plasma having measurable level of immunologically active immunoglobulin against anthrax to an unvaccinated animal, wherein antibody mediated protection against lethal infections of B.anthracis is elicited |
| 01/15/2004 | US20040009178 Human neutralizing antibodies (full-length or functional fragments) are useful as antitoxins or antiinfectives with respect to infective agents such as anthrax, botulinum, smallpox, Venezuelan equine encephalomyelitis, West Nile virus |
| 01/15/2004 | US20040009176 Treating inflammatory joint diseases by inhibiting cadherin-11 mediated cellular function |
| 01/15/2004 | US20040009174 Reducing inflammation in smooth muscle tissue in a subject by administering to subject an effective amount of an agent which inhibits OX40 ligand binding to OX40; treatment of asthma |
| 01/15/2004 | US20040009172 Biweekly subcutaneous administration of human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor alpha in combination with another drug which is useful for treating the disorder |
| 01/15/2004 | US20040009171 Methods for the treatment of carcinoma |
| 01/15/2004 | US20040009169 Administration of agents for the treatment of inflammation |
| 01/15/2004 | US20040009168 Multidose antibody formulation |
| 01/15/2004 | US20040009166 Single chain antigen-binding polypeptides for polymer conjugation |
| 01/15/2004 | US20040009164 PSP94 diagnostic reagents and assays |
| 01/15/2004 | US20040009163 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 01/15/2004 | US20040009147 Administering mixtures of antibodies and tumor necrosis factors, immunosuppressants, antibiotics, antiinflammatory agents, cytokines, angiogenesis inhibitors or fibroblast growth factors; prophylaxis of graft versus host disease |
| 01/15/2004 | US20040007530 Comprises ethylenediamine-N,N-tetra(methylenephosphonic) acid; for ion exchange/chromatography; improved biocompability |
| 01/15/2004 | DE10230550A1 Carbohydrate Deficient Transferrin (CDT)-spezifische Antikörper, ihre Herstellung und Verwendung Carbohydrate Deficient transferrin (CDT) -specific antibodies, their preparation and use |
| 01/15/2004 | DE10230516A1 Humaner monoklonaler Antikörper Human monoclonal antibodies |
| 01/15/2004 | CA2491947A1 The use of specified tcf target genes to identify drugs for the treatment of cancer, in particular colorectal cancer, in which tcf/.beta.-catenin/wnt signalling plays a central role |
| 01/15/2004 | CA2491669A1 Neoplasm specific antibodies and uses thereof |
| 01/15/2004 | CA2491488A1 Compositions and methods for the diagnosis and treatment of tumor |
| 01/15/2004 | CA2491471A1 Compositions, methods and kits relating to anti-platelet autoantibodies and inhibitors thereof |
| 01/15/2004 | CA2491286A1 Methods of screening compounds for grk6 modulating activity |
| 01/15/2004 | CA2491017A1 Antibodies to non-shed muc1 and muc16, and uses thereof |
| 01/15/2004 | CA2490708A1 Mutant fab fragments of the chimeric 13b8.2 anti-cd4 antibody and uses thereof |
| 01/15/2004 | CA2489860A1 Use of an antibody against s100a8 or s100a9 as chemotactic factor inhibitor for modulating inflammatory reactions |
| 01/15/2004 | CA2488885A1 Preparation based on an antibody directed against a tumor-associated glycosylation such as lewis structures |
| 01/14/2004 | EP1380653A1 Method of assaying lupus anticoagulant and assay reagent |
| 01/14/2004 | EP1380648A2 Recombinant DNAase B derived from streptococcus pyogenes |
| 01/14/2004 | EP1380646A1 Acetyllysine-recognizing monoclonal antibody and process for producing the same |
| 01/14/2004 | EP1380644A1 The use of specified TCF target genes to identify drugs for the treatment of cancer, in particular colorectal cancer, in which TCF/beta-catenin/WNT signalling plays a central role |
| 01/14/2004 | EP1380594A1 Fibroblast growth factor-10 |
| 01/14/2004 | EP1379873A2 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 01/14/2004 | EP1379872A2 Use of metabolic phenotyping in individualized treatment with amonafide |
| 01/14/2004 | EP1379695A2 New polynucleotides and polypeptides of the ifnalpha-21 gene |
| 01/14/2004 | EP1379688A2 Polymorphisms in the human cmoat gene and uses thereof |
| 01/14/2004 | EP1379679A2 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof |
| 01/14/2004 | EP1379672A2 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 01/14/2004 | EP1379662A2 Sulfatases and methods of use thereof |
| 01/14/2004 | EP1379657A2 Disease-associated protein |
| 01/14/2004 | EP1379656A2 G-protein coupled receptor molecules and uses thereof |
| 01/14/2004 | EP1379654A2 Intracellular signaling molecules |
| 01/14/2004 | EP1379652A2 Human nucleic acid molecules and polypeptides encoding a human ion channel expressed in spinal cord and brain |
| 01/14/2004 | EP1379651A2 Human genes and gene expression products isolated from human prostate |
| 01/14/2004 | EP1379650A2 Preferred segments of neural thread protein and methods of using the same |
| 01/14/2004 | EP1379648A1 Full-length human cdnas encoding potentially secreted proteins |
| 01/14/2004 | EP1379646A2 Engineered chimera of protein fragments and methods of use thereof |
| 01/14/2004 | EP1379638A2 Implantation serine proteinases |
| 01/14/2004 | EP1379637A2 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon |
| 01/14/2004 | EP1379635A2 Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions |
| 01/14/2004 | EP1379630A2 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase |
| 01/14/2004 | EP1379628A2 Kinases and phosphatases sequences, and use thereof |
| 01/14/2004 | EP1379557A2 Use of cd25 binding molecules in steroid-resistant patients |
| 01/14/2004 | EP1379556A1 Anti pilyrosporum ovale lgy and its uses |
| 01/14/2004 | EP1379538A1 Cea-expression inhibiting ribozymes and methods for the treatment of cancer based thereon |
| 01/14/2004 | EP1379282A2 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders |
| 01/14/2004 | EP1379277A2 Polyclonal populations of bispecific molecules and methods of production and uses thereof |
| 01/14/2004 | EP1379276A1 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 01/14/2004 | EP1379275A2 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses |
| 01/14/2004 | EP1379274A2 Methods for inhibition of angiogenesis, tumor growth and metastasis by fully human anti-il8 and anti-muc18 in diverse types of tumors |
| 01/14/2004 | EP1379272A2 Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies |
| 01/14/2004 | EP1379270A1 Method of inducing immune tolerance |
| 01/14/2004 | EP1379266A2 Modified annexin proteins and methods for preventing thrombosis |
| 01/14/2004 | EP1379125A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 01/14/2004 | EP0690991B2 Novel anticoagulant cofactor activity |
| 01/14/2004 | CN1468311A Isomaltulose synthase |
| 01/14/2004 | CN1468309A Anti-il-12 antibodies, compositions, methods and uses |
| 01/14/2004 | CN1468308A Anti-tnf antibodies, compositions, methods and uses |
| 01/14/2004 | CN1468307A Anti-dual integrin antibodies, compositions, methods and uses |
| 01/14/2004 | CN1468306A Schizophrenia related gene and protein |
| 01/14/2004 | CN1468259A Immunotherapy for chronic myelocytic leukemia |
| 01/14/2004 | CN1468250A Production of humanized antibodies in transgenic animals |
| 01/14/2004 | CN1468123A Method and composition for altering a b cell mediated pathology |
| 01/14/2004 | CN1467500A Immunoassay, reagent for immunoassay, and production method of the same |
| 01/14/2004 | CN1467223A Recombinated anti-CD25 monoclonal antibody, coding sequence and application |
| 01/14/2004 | CN1134266C Methods for inducing T cell tolerance to tissue or organ graft |
| 01/13/2004 | US6678651 Short-term enhancement in CELP speech coding |
| 01/13/2004 | US6677439 Methods for isolating T. pallidum rare outer membrane proteins |
| 01/13/2004 | US6677436 Humanized antibody against human tissue factor (TF) and process of production of the humanized antibody |
| 01/13/2004 | US6677434 Isolated mammalian nucleic acid molecule encoding a receptor protein tyrosine kinase expressed in primitive hematopcietic cells and not expressed in mature hematopoietic cells |
| 01/13/2004 | US6677428 Cdna with nucleotide sequence 1 and protein with amino acid sequence 2 |
| 01/13/2004 | US6677305 Insulin-like growth factor agonist molecules |
| 01/13/2004 | US6677146 Having at least 95% identity to amino acid sequence 10; stimulating processive dna replication |
| 01/13/2004 | US6677138 Production of a multimeric protein by cell fusion method |
| 01/13/2004 | US6677136 Glucagon antagonist domain, preferably having very little or no glucagon agonist activity, yeast-based screening phage display, rna- peptide screening, etc. attached to a vehicle, e.g., an fc domain, peg or dextran |
| 01/13/2004 | US6677126 Antibody for human translational regulator |
| 01/13/2004 | US6677124 Monoclonal antibody recognizing C-terminus of hBNP |
| 01/13/2004 | US6677118 Incubating under stringent hybridization conditions with nucleic acid probe |
| 01/13/2004 | US6676948 Haemophilus adherence and penetration proteins |
| 01/13/2004 | US6676945 Induction immunology response |